Glenmark Aspirin Capsules Recall: Capsule Breakage Risk
Glenmark recalls aspirin and dipyridamole capsules due to capsule breakage. Affected products include specific lot numbers and expiration dates. Consumers should check their product details and contact the manufacturer.
Lower-risk recall
Failed Tablet/Capsule Specification : Capsule breakage
Contact the company
What happened, in plain English
Glenmark is recalling aspirin and extended-release dipyridamole capsules that may break during use. This could lead to medication not working properly or causing injury if the capsule shatters inside the body. Read more at govinfonow.com/recall/34487-glenmark-aspirin-capsules-recall-capsule-breakage-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/34487-glenmark-aspirin-capsules-recall-capsule-breakage-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-1282-2022
Cite this page
“Glenmark Aspirin Capsules Recall: Capsule Breakage Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34487-glenmark-aspirin-capsules-recall-capsule-breakage-risk. Based on FDA recall #D-1282-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1282-2022%22&limit=1).
Why it’s dangerous
Capsules may break during use, which could cause the medication to not work as intended or potentially lead to injury if the broken capsule pieces enter the digestive tract.
Who’s affected
People with prescriptions for these capsules, especially those taking them for heart conditions. Those who have the specific lot numbers and expiration dates listed in the recall are most at risk.
How to tell if you have this one
Check the product label for the brand name Glenmark, the product name 'Aspirin and Extended-Release Dipyridamole Capsules', and the specific lot numbers and expiration dates listed in the recall.
- Brand
Glenmark- Category
Drug
What to do — step by step
Check Product Details
Look for the lot numbers and expiration dates listed in the recall notice to confirm if your product is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 28 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Glenmark recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1282-2022 (June 29, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1282-2022 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.